421 related articles for article (PubMed ID: 15004194)
1. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
Yamada K; Miwa T; Liu J; Nangaku M; Song WC
J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
[TBL] [Abstract][Full Text] [Related]
2. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice.
Bongoni AK; Lu B; Salvaris EJ; Roberts V; Fang D; McRae JL; Fisicaro N; Dwyer KM; Cowan PJ
J Immunol; 2017 Jun; 198(12):4837-4845. PubMed ID: 28500075
[TBL] [Abstract][Full Text] [Related]
4. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.
Zhang J; Hu W; Xing W; You T; Xu J; Qin X; Peng Z
Am J Pathol; 2011 Dec; 179(6):2876-84. PubMed ID: 22019898
[TBL] [Abstract][Full Text] [Related]
5. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
6. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
[TBL] [Abstract][Full Text] [Related]
7. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
Bao L; Haas M; Minto AW; Quigg RJ
Lab Invest; 2007 Apr; 87(4):357-64. PubMed ID: 17259999
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
Park P; Haas M; Cunningham PN; Alexander JJ; Bao L; Guthridge JM; Kraus DM; Holers VM; Quigg RJ
J Am Soc Nephrol; 2001 Jul; 12(7):1383-1390. PubMed ID: 11423567
[TBL] [Abstract][Full Text] [Related]
9. Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.
Lin F; Salant DJ; Meyerson H; Emancipator S; Morgan BP; Medof ME
J Immunol; 2004 Feb; 172(4):2636-42. PubMed ID: 14764738
[TBL] [Abstract][Full Text] [Related]
10. CD59a deficiency exacerbates ischemia-reperfusion injury in mice.
Turnberg D; Botto M; Lewis M; Zhou W; Sacks SH; Morgan BP; Walport MJ; Cook HT
Am J Pathol; 2004 Sep; 165(3):825-32. PubMed ID: 15331407
[TBL] [Abstract][Full Text] [Related]
11. High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone.
Cowan PJ; Shinkel TA; Aminian A; Romanella M; Wigley PL; Lonie AJ; Nottle MB; Pearse MJ; d'Apice AJ
Xenotransplantation; 1998 Aug; 5(3):184-90. PubMed ID: 9741456
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy.
Marshall KM; He S; Zhong Z; Atkinson C; Tomlinson S
J Exp Med; 2014 Aug; 211(9):1793-805. PubMed ID: 25113972
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated gene transfer of double human complement regulating proteins (DAF, CD59) in xenogeneic rat kidney perfusion.
Nagahama M; Shiraishi M; Taira K; Ohshiro T; Muto Y
Transplant Proc; 2000 Aug; 32(5):909-10. PubMed ID: 10936269
[No Abstract] [Full Text] [Related]
14. CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.
An G; Miwa T; Song WL; Lawson JA; Rader DJ; Zhang Y; Song WC
Mol Immunol; 2009 May; 46(8-9):1702-9. PubMed ID: 19297024
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
[TBL] [Abstract][Full Text] [Related]
16. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
Fodor WL; Rollins SA; Guilmette ER; Setter E; Squinto SP
J Immunol; 1995 Nov; 155(9):4135-8. PubMed ID: 7594566
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
Yang X; Deng J; Jiang Z; Liao DJ; Jiang H
Exp Clin Transplant; 2012 Feb; 10(1):49-54. PubMed ID: 22309420
[TBL] [Abstract][Full Text] [Related]
18. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
[TBL] [Abstract][Full Text] [Related]
19. Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.
Hu C; Li L; Ding P; Li L; Ge X; Zheng L; Wang X; Wang J; Zhang W; Wang N; Gu H; Zhong F; Xu M; Rong R; Zhu T; Hu W
J Immunol; 2018 Dec; 201(12):3717-3730. PubMed ID: 30429287
[TBL] [Abstract][Full Text] [Related]
20. Shear stress-mediated changes in the expression of complement regulatory protein CD59 on human endothelial progenitor cells by ECM-integrinα
Cui X; Zhang X; Bu H; Liu N; Li H; Guan X; Yan H; Wang Y; Zhang H; Ding Y; Cheng M
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):416-421. PubMed ID: 28943429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
